Simó JM - Search Results

1

Toxicity of lovastatin in rats with experimentally induced nephrotic syndrome.

Joven J, Vilella E, Camps J, Masana L, Turner PR, Simó JM, Villabona C. Joven J, et al. Among authors: simo jm. Nephron. 1990;56(4):399-404. doi: 10.1159/000186183. Nephron. 1990. PMID: 2079999

2

Serum fructosamine concentration in patients with nephrotic syndrome and with cirrhosis of the liver: the influence of hypoalbuminaemia and hypergammaglobulinaemia.

Constanti C, Simo JM, Joven J, Camps J. Constanti C, et al. Among authors: simo jm. Ann Clin Biochem. 1992 Jul;29 ( Pt 4):437-42. doi: 10.1177/000456329202900412. Ann Clin Biochem. 1992. PMID: 1642452

3

Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.

Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C. Joven J, et al. Among authors: simo jm. Clin Chem. 1995 Jun;41(6 Pt 1):908-13. Clin Chem. 1995. PMID: 7768011

4

Semiautomated determination of glycated albumin in glycaemic control of diabetic patients.

Cabre M, Joven J, Simo JM, Matas C, Camps J. Cabre M, et al. Among authors: simo jm. Clin Biochem. 1994 Aug;27(4):307-9. doi: 10.1016/0009-9120(94)90034-5. Clin Biochem. 1994. PMID: 8001294 Clinical Trial. No abstract available.

5

Automated latex agglutination immunoassay of serum ferritin with a centrifugal analyzer.

Simó JM, Joven J, Clivillé X, Sans T. Simó JM, et al. Clin Chem. 1994 Apr;40(4):625-9. Clin Chem. 1994. PMID: 8149621

6

Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery.

Sans T, Bofil C, Joven J, Clivillé X, Simó JM, Llobet X, Peró A, Galbany J. Sans T, et al. Among authors: simo jm. Transfusion. 1996 Sep;36(9):822-6. doi: 10.1046/j.1537-2995.1996.36996420762.x. Transfusion. 1996. PMID: 8823459 Clinical Trial.

7

The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia.

Joven J, Espinel E, Simó JM, Vilella E, Camps J, Oliver A. Joven J, et al. Among authors: simo jm. Atherosclerosis. 1996 Oct 25;126(2):243-52. doi: 10.1016/0021-9150(96)05905-9. Atherosclerosis. 1996. PMID: 8902150

8

Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity.

Joven J, Clivillé X, Camps J, Espinel E, Simó J, Vilella E, Oliver A. Joven J, et al. Clin Chem. 1997 Jul;43(7):1223-31. Clin Chem. 1997. PMID: 9216460

9

Evaluation of a homogeneous assay for high-density lipoprotein cholesterol: limitations in patients with cardiovascular, renal, and hepatic disorders.

Simó JM, Castellano I, Ferré N, Joven J, Camps J. Simó JM, et al. Clin Chem. 1998 Jun;44(6 Pt 1):1233-41. Clin Chem. 1998. PMID: 9625047 Clinical Trial.

10

Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction.

Joven J, Simó JM, Vilella E, Camps J, Masana L, de Febrer G, Camprubí M, Richart C, Bardaji A, Casao E, Pocovi M, Civeira F. Joven J, et al. Among authors: simo jm. Atherosclerosis. 1998 Sep;140(1):155-9. doi: 10.1016/s0021-9150(98)00076-8. Atherosclerosis. 1998. PMID: 9733226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters